Immunic

$15.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+0.25%) As of 4:12 PM UTC today

Why Robinhood?

You can buy or sell Immunic and other stocks, options, and ETFs commission-free!

About IMUX

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA. The listed name for IMUX is Immunic, Inc. Common Stock.

CEO
Daniel Vitt
Employees
26
Headquarters
New York, New York
Founded
—
Market Cap
347.56M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
545.60K
High Today
$16.51
Low Today
$15.78
Open Price
$16.19
Volume
114.65K
52 Week High
$28.21
52 Week Low
$4.19

IMUX Earnings

-$1.52
-$1.01
-$0.51
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
-$0.42 per share

You May Also Like

SGSOY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure